TipRanks
Phio Pharmaceuticals (DE:44R1)
MUNICH:44R1
Germany Market
44R1
Phio Pharmaceuticals
RESEARCH TOOLSreports

Phio Pharmaceuticals (44R1) Income Statement

3 Followers

Phio Pharmaceuticals Income Statement

Last quarter (Q2 2026), Phio Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Phio Pharmaceuticals's net income was $-4.14M. See Phio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -4.62M$ -3.64M$ -6.33M$ -7.01M$ -8.89M
Operating Expenses
$ 4.60M$ 3.74M$ 4.49M$ 4.45M$ 4.63M
Depreciation and Amortization
$ 3.00K$ 35.00K$ 184.00K$ 193.00K$ 75.00K
EBITDA
$ -8.70M$ -7.12M$ -10.64M$ -11.29M$ -13.21M
Operating Income
$ -9.22M$ -7.39M$ -10.82M$ -11.46M$ -13.51M
Other Income/Expenses
$ 522.00K$ 237.00K$ -2.00K$ -18.00K$ 224.00K
Pretax Income
$ -8.70M$ -7.15M$ -10.83M$ -11.48M$ -13.29M
Net Income
$ -8.70M$ -7.15M$ -10.83M$ -11.48M$ -13.29M
Per Share Metrics
Basic EPS
$ -1.45$ -0.91$ -46.87$ -89.61$ -111.32
Diluted EPS
$ -1.45$ -0.91$ -46.76$ -89.61$ -111.32
Weighted Average Shares Outstanding
 5.98M 787.47K 231.00K 126.16K 118.68K
Weighted Average Shares Outstanding (Diluted)
 5.98M 787.47K 231.51K 126.16K 118.68K
Currency in USD

Phio Pharmaceuticals Earnings and Revenue History